Download PDF

1. Company Snapshot

1.a. Company Description

LNA Santé SA engages in the management and operation of health establishments.The company operates retirement homes, medical and rehabilitation care, home hospital, mental health clinic, and health center.LNA Santé SA was founded in 1990 and is based in Vertou, France.

Show Full description

1.b. Last Insights on LNA

Have nothing to say about that one ...

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.16%)

6. Segments

Sanitary

Expected Growth: 8.5%

Sanitary segment's 8.5% growth driven by increasing healthcare expenditure, aging population, and rising demand for hygiene products. Government initiatives promoting public health, growing awareness of infectious diseases, and expanding healthcare infrastructure also contribute to growth. Additionally, LNA Santé SA's strategic investments in R&D and marketing efforts enhance product offerings and customer reach.

Medical-Social France

Expected Growth: 7.5%

Medical-Social France from LNA Santé SA's 7.5% growth is driven by an aging population, increasing healthcare expenditure, and government initiatives promoting home care services. Additionally, the segment benefits from a shortage of healthcare professionals, leading to a higher demand for LNA Santé's services.

International Trade

Expected Growth: 10.2%

LNA Santé SA's 10.2% growth in international trade is driven by increasing demand for healthcare products, strategic expansion into emerging markets, and a competitive pricing strategy. Additionally, the company's focus on product diversification, investment in digital marketing, and strengthening of logistics and distribution networks have contributed to its growth.

Real Estate

Expected Growth: 6.8%

The 6.8% growth in Real Estate from LNA Santé SA is driven by increasing demand for healthcare facilities, aging population, and government initiatives to improve healthcare infrastructure. Additionally, the growing need for specialized care and medical tourism are contributing to the segment's growth.

Others

Expected Growth: 8.0%

LNA Santé SA's 8.0% growth is driven by increasing demand for healthcare services, expansion into new markets, strategic partnerships, and investments in digital transformation. Additionally, the company's focus on preventive care and wellness programs, as well as its diversified portfolio of healthcare services, contribute to its growth momentum.

7. Detailed Products

Medical Imaging

LNA Santé SA provides medical imaging solutions for hospitals and clinics, offering a range of imaging modalities including MRI, CT, and X-ray.

Radiation Therapy

LNA Santé SA offers radiation therapy solutions for cancer treatment, providing advanced technology for precise and effective treatment.

Patient Monitoring

LNA Santé SA provides patient monitoring solutions for hospitals and clinics, enabling real-time monitoring and data analysis for improved patient care.

Medical Software

LNA Santé SA offers medical software solutions for healthcare providers, including electronic health records, practice management, and billing systems.

Medical Equipment

LNA Santé SA provides a range of medical equipment, including ultrasound, anesthesia, and surgical equipment, for hospitals and clinics.

8. LNA Santé SA's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for LNA Santé SA is moderate, as there are some alternative healthcare services available, but they are not highly substitutable.

Bargaining Power Of Customers

The bargaining power of customers for LNA Santé SA is low, as individuals have limited negotiating power when it comes to healthcare services.

Bargaining Power Of Suppliers

The bargaining power of suppliers for LNA Santé SA is moderate, as there are several suppliers of medical equipment and services, but some have more negotiating power than others.

Threat Of New Entrants

The threat of new entrants for LNA Santé SA is high, as the healthcare industry is constantly evolving and new players are entering the market.

Intensity Of Rivalry

The intensity of rivalry for LNA Santé SA is high, as there are many established players in the healthcare industry, and competition for patients and market share is fierce.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 61.90%
Debt Cost 4.72%
Equity Weight 38.10%
Equity Cost 7.53%
WACC 5.79%
Leverage 162.44%

11. Quality Control: LNA Santé SA passed 3 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Terveystalo

A-Score: 6.2/10

Value: 6.8

Growth: 5.4

Quality: 6.1

Yield: 7.5

Momentum: 5.0

Volatility: 6.7

1-Year Total Return ->

View Full Report
Stock-Card
LNA Santé

A-Score: 4.9/10

Value: 8.4

Growth: 4.6

Quality: 3.1

Yield: 3.1

Momentum: 6.0

Volatility: 4.3

1-Year Total Return ->

View Full Report
Stock-Card
Spire Healthcare

A-Score: 4.4/10

Value: 5.4

Growth: 6.4

Quality: 2.4

Yield: 0.6

Momentum: 6.0

Volatility: 5.3

1-Year Total Return ->

View Full Report
Stock-Card
Aevis Victoria

A-Score: 4.4/10

Value: 2.9

Growth: 4.8

Quality: 3.4

Yield: 2.5

Momentum: 5.5

Volatility: 7.0

1-Year Total Return ->

View Full Report
Stock-Card
RHOEN-KLINIKUM

A-Score: 4.3/10

Value: 7.9

Growth: 5.6

Quality: 5.2

Yield: 0.6

Momentum: 1.5

Volatility: 5.0

1-Year Total Return ->

View Full Report
Stock-Card
Ramsay Santé

A-Score: 3.8/10

Value: 8.9

Growth: 3.9

Quality: 1.7

Yield: 0.0

Momentum: 1.0

Volatility: 7.3

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

23.4$

Current Price

23.4$

Potential

-0.00%

Expected Cash-Flows